Coherus BioSciences Inc (CHRS) Stock Price Today & Analysis

CHRS
CHRS company logo
Loading...
Chart by TradingView

Valuation

Market cap$266.06M
Price-to-sales ratio6.33
Price-to-book value4.37
Price-earnings ratio1.60
Return on Equity-575.00%
Return on Sales4.40%
Return on Assets0.35%
PEG ratioN/A

Earnings Per Share

Earnings Per Share$1.43

Income Statement

Average volume1,555,686
EBITDA$167.70M
1 year high (52w)$2.62
1 year low (52w)$0.71

Dividend

Dividend yield0.00%

Solvency

Debt-to-equity ratioN/A

About Coherus BioSciences Inc

Coherus Oncology Inc is a fully integrated commercial-stage inventive oncology company with an approved next-generation PD-1 inhibitor, LOQTORZI, and a pipeline that includes two mid-stage clinical candidates targeting liver, lung, head & neck, and other cancers. Its strategy is to expand the use of LOQTORZI in NPC and advance the development of new indications for LOQTORZI in combination with both its pipeline candidates as well as its industry partners, driving synergies from proprietary combinations, including first-in-class anticancer agents. Its portfolio includes LOQTORZI, CHS-114, and Casdozokitug.

FAQ

Buying Coherus BioSciences Inc (CHRS) stock is now easy and instant through the Gotrade app.
  1. Download the Gotrade app from the App Store or Google Play.
  2. Create an account and complete KYC.
  3. Make a deposit.
  4. Search for the code "CHRS", then tap "Trade".
  5. Tap the "Buy" button.
  6. Enter the amount you want to buy. You have two options:
    1. Buy CHRS by number of shares.
    2. Buy fractional shares in dollars, starting from $1.
  7. Swipe up to confirm your order—done!

On Gotrade, you don't have to buy a full lot. With fractional shares, you can start investing in Coherus BioSciences Inc from just $1. A small budget shouldn't stop you from building a US stock portfolio.

At the moment, Coherus BioSciences Inc (CHRS) does not pay dividends because it focuses on reinvesting profits for company growth (a growth stock). However, you can still potentially earn profit from share price increases (capital gains). Track CHRS's performance via the price chart in the Gotrade app.

Gotrade is the trading name of Gotrade Securities Inc., which is registered with and supervised by the Labuan Financial Services Authority (LFSA).

You can place orders 24/7. Transactions will be executed when the US market (NYSE/NASDAQ) is open, from 9:30 PM to 4:00 AM WIB. Gotrade also provides access to pre-market and after-hours trading, so you have more flexibility and aren't limited to regular working hours.
Market hours may change due to daylight saving time and holidays. In Gotrade, you can see the market status (open/closed) directly in the app.

There's no single perfect answer, but common approaches include:
  • Compare valuation (e.g., P/E, P/S) against historical averages or competitors.
  • Review revenue and earnings growth.
  • Check margins and cash flow.
  • Evaluate business outlook and the company's position within its industry.
You can combine fundamental analysis with an investing strategy that matches your risk profile. All of the information above can be viewed directly in the Gotrade app.

Related news

AppLogo

Buy saham CHRS
di Gotrade

AppLogo

Gotrade